The present work describes the identification, purification, and characterization of bile salt hydrolase (BSH) from Bifidobacterium animalis subsp. lactis. The enzyme was purified to electrophoretic homogeneity by hydrophobic chromatography, ion-exchange chromatography and ultrafiltration. SDS-PAGE analysis of putative BSH and gel filtration revealed that the analyzed protein is presumably a tetramer composed of four monomers each of about 35 kDa. The purified enzyme was analyzed by liquid chromatography coupled to LTQ FT ICR mass spectrometry and unambiguously identified as a bile salt hydrolase from B. animalis. The isoelectric point of the studied protein was estimated to be around pH 4.9. The pH optimum of the purified BSH is between 4.7 to 6.5, and the temperature optimum is around 50 o C. The BSH of B. animalis could deconjugate all tested bile salts, with clear preference for glycine-conjugated bile salts over taurine-conjugated forms. Genetic analysis of the bsh showed high similarity to the previously sequenced bsh gene from B. animalis and confirmed the usefulness of bile salt hydrolase as a genetic marker for B. animalis identification.
Genus Bifidobacterium constitutes a group of Gram-positive, nonmotile, nonsporulating, non-gas-producing, catalasenegative, and anaerobic bacteria that are natural inhabitants of human and animal gastrointestinal tracts. Because of their different health-promoting properties, some of these characteristic Y-or V-shaped rods have been intensively investigated for industrial application as food additives and probiotic pharmaceuticals [1, 9, 28, 34] . Many studies have shown that members of Bifidobacterium may stimulate the intestinal immune system [6, 33] , and decrease lactose intolerance [14] , and can reduce the effects of diarrhea, constipation, and inflammatory bowel disease [21] . Moreover, some evidence suggests that bifidobacteria can prevent or delay the onset of colorectal cancer [20] , and finally, by reducing serum cholesterol concentration, to decrease the risk of cardiovascular disease [29] .
In recent years, the possibility of using probiotic bacteria to lower the cholesterol level in hypercholesterolemic patients and to prevent hypercholesterolemia in healthy people has been extensively analyzed [8, 32] . Abundant studies have shown various mechanisms for the cholesterol lowering action of lactic acid bacteria [23, 26, 29] . The most promising route of this process is the occurrence of bile salt hydrolase (BSH) activity in such intestinal commensals such as Bifidobacterium. BSH is an enzyme that catalyzes the hydrolysis of glycine-and taurine-conjugated bile salts into amino acid residues and bile acids [16, 27] . Free bile acids are less efficiently reabsorbed than conjugated bile salts, which results in the excretion of larger amounts of deconjugated bile salts via feces. Therefore, bile salt hydrolase activity could lead to the increased requirement for cholesterol, which is a precursor for the synthesis of bile salts, and finally could bring about a lowering of the serum cholesterol level [2] . On the other hand, some researchers suggest that BSH activity may also cause detrimental effects on human health. It has been proposed that bile salt hydrolase activity in enteric bacteria might have a major role in the formation of gallstones [4] , lipid malabsorption [27] , and might even promote an activation of carcinogens [3, 25] . These effects seem to be especially important as some bifidobacteria strains such as Bifidobacterium animalis Bb12 and Bifidobacterium animalis DN-173 010 are commonly used as food additives in the dairy industry.
In this study, we present the characterization of the bile salt hydrolase activity of Bifidobacterium animalis Bi30. Although the bsh promoter and operon-like structure containing the bsh gene from Bifidobacterium animalis were previously described [19] , the BSH enzyme from this *Corresponding author Phone: +48 81 462 33 51; Fax: +48 81 462 34 00; E-mail: piotr.jarocki@wp.pl species has not yet been characterized. In our work, BSH was purified and selected biochemical characteristics were analyzed. Next, the whole bsh gene was amplified and sequenced, and the obtained result was aligned with bsh genes present in GenBank.
MATERIALS AND METHODS

Microorganisms and Culture Conditions
Bifidobacterium strains used in this work, B. animalis Bi30, B. catenulatum KD14, B. infantis ATCC 15697, and B. longum KN29, were obtained from the Food Science Institute of Animal Reproduction and Food Research of The Polish Academy of Sciences, Olsztyn, Poland. All strains were routinely anaerobically cultured in a modified Garche's medium at 37
To detect bile salt hydrolase activity, a solidified medium was supplemented with 0.5% (w/v) of the sodium salt of taurodeoxycholic acid (TDCA). Plates were incubated anaerobically for 72 h at 37
. Escherichia coli XL1 Blue (Stratagene Inc.) was used as a host, and pGEM-T Easy vector (Promega) was used for cloning of the PCR product and DNA sequencing. E. coli cells were routinely cultured in Luria-Bertani (LB) broth at 37 o C with vigorous shaking or on LB medium solidified with 1.5% agar, and ampicillin (100 µg/ml) was added, if necessary.
Cell Extracts Preparation and BSH Assays
For cell-free extracts preparation, cells of overnight culture were harvested by centrifugation at 10,000 ×g for 10 min at 4 o C. The cell pellet was washed twice in 0.1 M sodium-phosphate buffer (pH 7.0) and then resuspended into 20 ml of the same buffer containing 10 mM 2-mecaptoethanol (Sigma Aldrich). The cells were disrupted by sonication for 3 min with constant cooling, followed by centrifugation at 20,000 ×g for 10 min at 4 o C. The supernatant was stored at -20 o C. BSH activity assay was performed by determining the amount of liberated amino acids from hydrolysis of the amide bond of conjugated bile salts as described previously [16, 30] , with several modifications. To 180 µl of 0.1 M sodium-phosphate buffer (pH 6.0) containing 10 mM 2-mercaptoethanol, 10 µl of 200 mM human bile salt mix (12% taurocholic acid, 8% taurodeoxycholic acid, 12% taurochenodeoxycholic acid, 23% glycocholic acid, 16% glycodeoxycholic acid, and 23% glycochenodeoxycholic acid) and 10 µl of the protein sample in the appropriate dilution were added. The bile salts mixture was used to measure the overall activity of bile salt hydrolase. In order to determine substrate specificity, reactions with individual bile salts (final concentration, 10 mM) were prepared. The reaction mixture was incubated at 37 o C for 30 min. The enzymatic reaction was terminated with 200 µl of 15% (w/v) TCA and then the samples were centrifuged at 14,000 ×g to remove the precipitate. The amounts of amino acids released from the conjugated bile salts were measured by the ninhydrin assay. One unit of BSH activity was defined as the amount of enzyme that can liberate 1 µmol of amino acid from a substrate per minute.
Activity Staining on a Polyacrylamide Gel
The identification of BSH activity in cell-free extracts and in purified protein sample was carried out in a nondenaturating 10% (w/v) acrylamide gel with Laemmli buffer system, ommiting SDS [10] . After electrophoretic separation, the gel was washed twice in 0.4 M sodium-acetate buffer (pH 4.5) with 10 mM 2-mercaptoethanol and then incubated at 37 o C for 1 h in 0.1 M sodium-phosphate buffer (pH 6.0) containing 10 mM 2-mercaptoethanol and 10 mM sodium salt of taurodeoxycholic acid. The BSH activity in the gel was visualized by the formation of a white precipitate of deoxycholic acid at the position of the enzyme.
Purification and Molecular Mass Estimation of BSH
The cell-free extract was loaded onto a Phenyl-Sepharose hydrophobic interaction chromatography (HIC) column (1×5 cm), which had been equilibrated in 50 mM sodium-phosphate buffer containing 0.8 M sodium sulfate at a flow rate of 1 ml/min. The absorbed proteins were eluted with a decreasing linear sodium sulfate gradient (0.8 to 0 M) and the collected fractions (2 ml) were assayed for BSH activity. The fractions containing more than 50% of the peak activity were pooled, desalted, and concentrated using the Vivaspin 20 centrifugal concentrator (10,000 MWCO; Sartorius, AG, Goettingen, Germany). The concentrated BSH active fraction obtained from HIC was applied to a Q-Sepharose anion-exchange chromatography column (1×5 cm) that was equilibrated with 50 mM bis-Tris propane buffer (pH 6.5). The elution was performed using a linear gradient of 1 M sodium chloride in 50 mM bis-Tris propane buffer (pH 6.5). The flow rate was 1 ml/min. Fractions (2 ml) were collected and assayed for BSH activity. The active fractions were then concentrated and used for further characterization. The protein purity was examined by SDS-PAGE according to Laemmli using a stacking gel containing 4% acrylamide and 12% resolving gel. The accurate subunit molecular mass was determined by comparing its migration with the molecular mass standards (Fermentas). The proteins were visualized by staining with Coomassie Brilliant Blue R-250. The native molecular mass of BSH was estimated by size-exclusion chromatography using a Sephacryl S-300 HR 1.5×100 cm column (Sigma Aldrich). The enzyme was eluted with 0.1 M sodium-phosphate buffer (pH 7.0) containing 0.15 M sodium chloride at the flow rate of 0.5 ml/min. The molecular weight standard kit was obtained from Bio-Rad. All chromatographic separations were performed using a BioLogic Duo Flow system (Bio-Rad).
Isoelectric Focusing and 2D Electrophoresis
In order to improve the isoelectric focusing, protein samples were prepared with a 2D Clean-Up kit (Amersham Biosciences) and then protein pellets were dissolved in rehydration buffer (Bio-Rad) containing 8 M urea, 2% (w/v) CHAPS, 50 mM DTT, 0.2% (v/v) Bio-Lyte 3/10 ampholyte, and 0.001% (w/v) Bromophenol Blue (Bio-Rad). Proteins were subjected to active rehydration (12 h; 50 V; 20 o C) on 7 cm, pH 3-10 linear IPG strips and then to isoelectric focusing by using Protean IEF (Bio-Rad) for a total of 14 kVh at 20 o C under mineral oil to prevent evaporation. After focusing, the IPG strips were equilibrated in 6 M urea, 2% (v/v) glycerol, and 0.375 M Tris-HCl (pH 8.8), reduced with 2% (w/v) DTT and alkylated with 135 mM iodoacetamide. For the second dimension, the IEF strips were transferred to 10% polyacrylamide gels, sealed with 0.5% (w/v) low melting point agarose containing Bromophenol Blue in 25 mM Tris, 192 mM glycine, and 0.1% (w/v) SDS, and then the electrophoresis was carried out at 200 V for 40 min using Mini Protean (Bio-Rad).
To obtain the precise determination of the isoelectric point, wide pH range strips (pH 3.0 to 10.0, 17 cm) were used. After isoelectric focusing (IEF), the proteins were visualized with CBB R250.
